หน้าแรก
ค้นหา
Josh Armenia on Results of Mutated Gene Analysis in Prostate Cancer
No description available
แสดงข้อมูลเพิ่มเติม 1
Josh Armenia on Results of Mutated Gene Analysis in Prostate Cancer
Josh Armenia on Impact of Mutated Gene Analysis in Prostate Cancer
Dr. Armenia on the Significance of Analyzing Gene Mutations in Prostate Cancer
Understanding Prostate Cancer Mutations Is Critical
Dr. Abida on Genetic Testing for Prostate Cancer
J Winter: Discovering novel susceptibility genes for aggressive prostate cancer.
Webinar: Parp-Inhibitors and Prostate Cancer - Gotta Have a Mutation??? 06/29/2023
Dr. Spratt on Growing Role for Genetic Testing in Prostate Cancer
Next Generation Sequencing of Prostate Tumors: Use of Individualized Biomarkers
The drug’s called Pluvicto and it was approved in early 2022 for PMSA+ prostate cancer
Dr. Stacy Loeb on Considerations for Screening in Prostate Cancer
Dr. Rathkopf on Investigative Agents in Prostate Cancer
Where can PARP inhibitors be used
Dr. Olsson on Differences Between LHRH Agonists and Antagonists in Prostate Cancer
Dr. Micallef on NuQ Blood Tests in Prostate Cancer
Dr. Marc Bjurlin on Predictive Models for Prostate Cancer Risk
Dr. Michael Brawer on Predicting Prostate Cancer Aggressiveness
Dr. Scher on Promise of Liquid Biopsies in Prostate Cancer
Dr. Eggener on PSA-Based Screening in Early-Stage Prostate Cancer
Dr. Richard Harris on Advancements on the Horizon in Prostate Cancer
